Insurance and risk management company Aon Corporation (NYSE: AOC) is posting good returns in all three business units on the three most important quantitative metrics: organic growth, margin expansion, earnings improvement. The stock is worth considering as part of a balanced value-income portfolio. Its P/E multiple is just above industry standard, but its EPS is 50% above industry average. Even with a market cap in excess of $12 billion, AON stock still returns 10% quarterly growth year over year, far in excess of industry standard. The stock has already appreciated in price more than 15%, opening the year trading at $35.39 and closing on June 12 at $41.80.

Aon Corporation recently reported very good 1Q 2007 earnings. Revenue was up 10% for the quarter to $2.4 billion, 5% of which was due to organic growth. Net income increased 8% to $213 million or EPS of $0.66. Net income from continuing operations rose 23% to $212 million. Aon posted these numbers despite a tough North American market in which rising health care costs have put pressure on medical insurance and risk management companies. During this quarter, Aon realized restructuring savings of $46 million and is on track to realize FY 2007 savings of $235 million and FY 2008 savings of $280 million. The company also repurchased $345 million of its stock and has authorization from its board to repurchase up to $2 billion of its stock.

The Risk and Insurance Brokerage Service segment posted an impressive 8% gain in revenue due to new US business and 8% in Asia Pacific. Overall, this unit posted a 6% revenue increase despite soft markets in the UK and Australia. The Consulting unit increased revenue by 7% to $329 million despite the termination of large outsourcing contracts. The Insurance Underwriting unit grew revenue by 16% to $574 million, up $79 million from 1Q 2006. At the same time as it posted organic growth revenues, Aon Corporation also increased policyholder benefits 27% to $323 million. Clearly, Aon Corporation has developed a profitable business strategy even in the midst of a challenging economic and political environment regarding health care insurance costs.